Yazar "Fisgin, T" için listeleme
-
Acquired von Willebrand syndrome in a patient with Ewing sarcoma
Elli, M; Pinarli, FG; Dagdemir, A; Dabak, N; Fisgin, T; Selcuk, MB; Acar, S (Taylor & Francis Inc, 2006)Acquired von Willebrand syndronze is a rare bleeding disorder with clinical and laboratory features closely resembling to hereditary von Willebrand disease. The syndrome may accompany various conditions, including malignant ... -
Hematologic manifestation of childhood celiac disease
We wanted to describe the hematologic manifestations of celiac disease (CD) in childhood. This study included 22 children with CD in whom the disease remained undiagnosed until they had presented with hematological ... -
Hemostatic side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
Fisgin, T; Yarali, N; Kara, A; Bozkurt, C; Birgen, D; Erten, U; Duru, F (Taylor & Francis Inc, 2004)The purpose of this study is to investigate the hemostatic side effects of HDMTX. Between 2001 and 2002, 20 children with acute lymphoblastic leukemia at the Dr. Sami Ulus Children's Hospital, Department of Pediatric ... -
Oral and dental findings in Fanconi's anemia
Acikgoz, A; Ozden, FO; Fisgin, T; Acikgoz, G; Duru, F; Yarali, N; Albayrak, D (Taylor & Francis Inc, 2005)Fanconi's anemia is an autosomal recessive disorder characterized by progressive pancytopenia and congenital malformation of the skeleton. This study investigated the oral health status of 15 children with Fanconi's anemia, ... -
Renal amyloidosis due to pulmonary tuberculosis in a patient with Down syndrome
Ozkaya, O; Paksu, MS; Bek, K; Yildizz, L; Fisgin, T; Gurmen, N; Karagoz, F (Springer, 2006)A pulmonary-tuberculosis-related renal amyloidosis patient with Down syndrome, who presented with nephrotic syndrome, was studied. -
Serum transferrin receptor levels in beta-thalassemia trait
Increased levels of transferrin receptors (TfR) and soluble TfR (sTfR) are reliable indicators of iron deficiency anemia and conditions with enhanced erythropoietic activity. In this study wemeasured sTfR levels in the ... -
Subcutaneous bolus injection of deferoxamine is an alternative method to subcutaneous continuous infusion
Yarali, N; Fisgin, T; Duru, F; Kara, A; Ecin, N; Fitoz, S; Erden, I (Lippincott Williams & Wilkins, 2006)The objective of this study was to compare the short- and long-term efficacy of deferoxamine (DFO) given by subcutaneous (SC) continuous infusion over 10 hours via a pump (n = 10) versus a twice-daily subcutaneous bolus ... -
Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child
Yarali, N; Fisgin, T; Duru, F; Atilla, P; Muftuoglu, SF; Kaymaz, SF (Taylor & Francis Inc, 2005)Congenital dyserythropoietic anemia type I (CDA 1) is a rare inherited hematological disorder characterized by macrocytic anemia and ineffective erythropoiesis with pathognomonic morphological features that, include ...
